Oral substitution treatment of injecting opioid users for prevention of HIV infection (Q24234956)

23 October 2023

Linda Gowing

Linda

Gowing

1 reference

23 October 2023

Michael F Farrell

series ordinal

author given names

Michael F

author last names

Farrell

1 reference

23 October 2023

Reinhard Bornemann

series ordinal

author given names

Reinhard

author last names

Bornemann

1 reference

23 October 2023

Lynn E Sullivan

series ordinal

author given names

Lynn E

author last names

Sullivan

1 reference

Cochrane Database of Systematic Reviews

23 October 2023

language of work or name

1 reference

10 August 2011

0 references

published in

0 references

cites work

Retrospective analyses of additional services for methadone maintenance patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

AIDS risk behavior in opioid dependent patients treated with community reinforcement approach and relationships with psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Community reinforcement approach in the treatment of opiate addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Day treatment versus enhanced standard methadone services for opioid-dependent patients: a comparison of clinical efficacy and cost

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Gender, cocaine and during-treatment HIV risk reduction among injection opioid users in methadone maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Maintenance of HIV risk reduction among injection opioid users: a 12 month posttreatment follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Gender differences at admission and follow-up in a sample of methadone maintenance clients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Behavioral drug and HIV risk reduction counseling (BDRC) with abstinence-contingent take-home buprenorphine: a pilot randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Reduction or cessation of injecting risk behaviours? Treatment outcomes at 1-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

The National Treatment Outcome Research Study (NTORS): 4-5 year follow-up results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Patterns of improvement after methadone treatment: 1 year follow-up results from the National Treatment Outcome Research Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Reduced injection risk and sexual risk behaviours after drug misuse treatment: results from the National Treatment Outcome Research Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

HIV risk behaviors among women in methadone maintenance treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Ethnic differences in HIV risk behaviors, self-perceptions, and treatment outcomes among women in methadone maintenance treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Influence of psychiatric comorbidity on HIV risk behaviors: changes during drug abuse treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

The Effect of Methadone Maintenance on Illicit Opioid Use, Human Immunodeficiency Virus and Hepatitis C Virus Infection, Health Status, Employment, and Criminal Activity Among Heroin Abusers During 6 Months of Treatment in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

HIV risk behaviors during pharmacologic treatment for opioid dependence: a comparison of levomethadyl acetate [corrected] buprenorphine, and methadone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Changes in Cocaine Use After Entry to Methadone Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Profiles of self-reported HIV-risk behaviors among injection drug users in methadone maintenance treatment, detoxification, and needle exchange programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Buprenorphine treatment for opioid dependence: the relative efficacy of daily, twice and thrice weekly dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

HIV infection and cocaine use in methadone maintained and untreated intravenous drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Reduction in injection-related HIV risk after 6 months in a low-threshold methadone treatment program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Feasibility of buprenorphine and methadone maintenance programmes among users of home made opioids in Ukraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Feasibility of buprenorphine maintenance therapy programs in the Ukraine: first promising treatment outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Changes in HIV risk behaviors among patients receiving combined pharmacological and behavioral interventions for heroin and cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Methadone treatment as a determinant of HIV risk reduction among injecting drug users: a nested case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Client engagement and change during drug abuse treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Methadone maintenance treatment and HIV risk-taking behaviour among injecting drug users in Berlin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Randomized trial of supervised injectable versus oral methadone maintenance: report of feasibility and 6-month outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Methadone maintenance treatment and HIV type 1 seroconversion among injecting drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Hepatitis C and human immunodeficiency virus risk behaviors in polydrug users on methadone maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Levo-alpha-acetylmethadol (LAAM) versus methadone maintenance: 1-year treatment retention, outcomes and status

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Longitudinal effects of LAAM and methadone maintenance on heroin addict behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Risk Factors and predictors of human immunodeficiency virus infection among injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Ethnic differences in HIV risk behaviors among methadone-maintained women receiving contingency management for cocaine use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Patients successfully maintained with methadone escaped human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Reduction of AIDS risk among 41 heroin addicted female street prostitutes: effects of free methadone maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Drug injection cessation among HIV-infected injecting drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

HIV Infection Risk Behaviors and Methadone Treatment: Client-Reported HIV Infection in a Follow-up Study of Injecting Drug Users in New England

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

The early course of change in methadone maintenance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Methadone maintenance and the likelihood of risky needle-sharing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

The effect of methadone maintenance on positive outcomes for opiate injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Drug use, injecting practices and sexual behaviour of opioid users in Sydney, Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Incarceration and drug use patterns among a cohort of injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Antisocial personality disorder, HIV risk behavior and retention in methadone maintenance therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Validity of intravenous drug abusers' self-reported changes in HIV high-risk drug use behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Methadone maintenance in prison: evaluation of a pilot program in Puerto Rico

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Correlates of drug injection behaviors among methadone outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Methadone maintenance and cessation of injecting drug use: results from the Amsterdam Cohort Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Trends in HIV risk behaviour and methadone dosage among HIV-negative drug users: an ecological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Methadone maintenance and needle/syringe sharing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Sex, drugs and HIV counseling and testing: a prospective study of behavior-change among methadone-maintenance clients in New England

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Changes in HIV risk behaviors among cocaine-using methadone patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Behavioural change in injecting drug users: evaluation of an HIV/AIDS education programme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Binge drug use independently predicts HIV seroconversion among injection drug users: implications for public health strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Risk dimensions of HIV-tested substance users

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Long-term outcomes of office-based buprenorphine/naloxone maintenance therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Methadone treatment in the Scottish context: outcomes of a community-based service for drug users in Lothian

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Impact of methadone on drug use and risky sex in China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Buprenorphine in primary care: risk factors for treatment injection and implications for clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Longitudinal changes in injection behaviors in a cohort of injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Risk factors for human immunodeficiency virus infection in intravenous drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

A randomized controlled trial of interim methadone maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Interim methadone treatment: impact on arrests

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Impact of interim methadone maintenance on HIV risk behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Methadone maintenance and other factors associated with intraindividual temporal trends in injection-drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

HIV and hepatitis virus infections among injecting drug users in a medically controlled heroin prescription programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Infectious diseases and public health: risk-taking behavior during participation in the Swiss program for a medical prescription of narcotics (PROVE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Factors associated with incarceration and incident human immunodeficiency virus (HIV) infection among injection drug users participating in an HIV vaccine trial in Bangkok, Thailand, 1999-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

High-risk sexual behaviors of intravenous drug users in- and out-of-treatment: implications for the spread of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Retention in methadone maintenance is associated with reductions in different HIV risk behaviors for women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Injecting behaviour and risky needle use amongst methadone maintenance clients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Adherence to methadone is associated with a lower level of HIV-related risk behaviors in drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

HIV risk behavior in treatment-seeking opioid-dependent youth: results from a NIDA clinical trials network multisite study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Methadone maintenance at different dosages for opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Syringe-mediated drug sharing among injecting drug users: patterns, social context and implications for transmission of blood-borne pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Medical care for injection-drug users with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

AIDS and injecting drug use in the United Kingdom, 1987-1993: the policy response and the prevention of the epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

The Privatization of Methadone Maintenance; Changes in Risk Behavior Associated with Cost Related Detoxification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Impact of drug maintenance treatment on injection practices among French HIV-infected IDUs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

A Morphine Prescription Program in Italy (1980-1985): Retrospective Evidence of Protection Against Hiv/Aids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Heroin use and HIV risk-taking behaviour among women injecting drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

A Low Threshold Methadone Stabilisation Programme–Description and First Stage Evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Predictors of Opiate Drug Abuse during a 90-Day Methadone Detoxification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Patterns of Heroin, Cocaine and Speedball Injection Among Bronx (Usa) Methadone Maintenance Patients: 1978-1988

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Outcomes of a 21-Day Drug Detoxification Program: Retention, Transfer to Further Treatment, and HIV Risk Reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Short-term Outcomes for the Treatment of Heroin Dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

Comparing opiate users in methadone treatment with untreated opiate users: results of a follow-up study with a Toronto opiate user cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

7 January 2021

[Prevalence of infection by HIV and hepatitis C virus in a cohort of patients on methadone treatment]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

7 January 2021

Self-report among injecting drug users: a review

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

7 January 2021

Levels of intravenous drug misuse among clients prescribed oral dexamphetamine or oral methadone: a comparison

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

7 January 2021

What happens when a demonstration project ends. Consequences for a clinic and its clients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

7 January 2021

Sex, drugs, and HIV: does methadone maintenance reduce drug use and risky sexual behavior?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

7 January 2021

When is less treatment better? The role of social anxiety in matching methadone patients to psychosocial treatments

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

7 January 2021

Methadone maintenance treatment reduces heroin injection in New South Wales prisons

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

7 January 2021

A Trial of Integrated Buprenorphine/Naloxone and HIV Clinical Care

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

7 January 2021

Methadone maintenance treatment modalities in relation to incidence of HIV: results of the Amsterdam cohort study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

7 January 2021

Reduced infections with HIV and hepatitis A during a Swiss intravenous opiate maintenance program

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

7 January 2021

Methadone maintenance as HIV risk reduction with street-recruited injecting drug users

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

7 January 2021

Effectiveness of first eight methadone maintenance treatment clinics in China

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

7 January 2021

The sharing of injecting equipment among drug users attending prescribing clinics and those using needle-exchanges

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

7 January 2021

Antisocial personality disorder and HIV infection among intravenous drug abusers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

7 January 2021

Drug abuse treatment as HIV prevention: changes in social drug use patterns might also reduce risk

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

7 January 2021

HIV prevalence and risk behavior among injecting drug users who participate in "low-threshold" methadone programs in Amsterdam

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

7 January 2021

Risk factors for HIV-1 seroconversion among injection drug users: a case-control study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

7 January 2021

Retention, HIV risk, and illicit drug use during treatment: methadone dose and visit frequency

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

7 January 2021

A Controlled Trial of Methadone Maintenance in a Population of Intravenous Drug Users in Bangkok: Implications for Prevention of HIV

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

7 January 2021

Reducing HIV risk behavior among injection drug users: effect of methadone maintenance treatment on number of sex partners

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004145.PUB4

7 January 2021